与Knobloch综合征2型相关的新型酶缺乏PAK2变异
Rhonda E Schnur1,2, Lukáš Dvořáček3, Louisa Kalsner4
1Cooper Medical School of Rowan University, Camden, New Jersey, USA.
Clinical genetics
|June 19, 2024
概括
一种新的p21激活酶2 (PAK2) 变体导致酶缺乏,将PAK2与第二种形式的自体主导诺布洛赫综合征 (KNO2) 联系起来. 这一发现促进了对影响细胞骨组织的遗传疾病的理解.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 发育生物学 发展生物学
背景情况:
- 激活p21酶 (PAK) 家族调节细胞骨动力学,对细胞粘附,迁移,增殖和细胞亡至关重要.
- 特别是PAK2在细胞亡,血管新生和内皮细胞发育中起作用.
- 诺布洛奇综合征是一种罕见的遗传性疾病,其特征是头脑,眼睛异常和发育迟缓.
研究的目的:
- 调查PAK2变异在Knobloch综合征中的作用.
- 为了确定Knobloch综合征的新型遗传原因.
- 为了阐明已识别的PAK2变异的功能后果.
主要方法:
- 基因测序用于识别Knobloch综合征患者的变异.
- 试验室内激酶活性测定用于评估PAK2变异的功能影响.
- 对以前报告的与类似表型相关的PAK2变体的文献综述.
主要成果:
- 在一个患有Knobloch综合征的新生儿身上发现了一种新的异构错误PAK2变体,p.
- 在体外实验表明,p.(Thr406Met) 和之前报告的变种p.(Asp425Asn) 的激酶活性明显受损.
- 这些发现与之前报告的PAK2变异 (例如,p.(Glu435Lys)) 与拟议的Knobloch综合征2型 (KNO2) 相关的结果一致.
结论:
- 鉴定到的PAK2变体支持PAK2激酶缺乏与第二种自体主导形式的Knobloch综合征的关联,该形式被指定为KNO2.
- 帕克2激酶缺乏是新发现的自体主导诺布洛赫综合征的原因.
- 这项研究扩大了Knobloch综合征的遗传基础,并强调了PAK2在发育中的关键作用.
相关概念视频
Cytoskeletal Linker Proteins - Plakins
2.3K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.3K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Enzyme-linked Receptors
78.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.0K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K


